About: Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)
Creator	Annane, Djillali Gattinoni, Luciano Caironi, Pietro Malbrain, Manu Regenmortel, Niels Wong, Adrian Elbers, Paul De Laet 10, Inneke Hahn, Robert Langer, Thomas Minini, Andrea Muckart, David Mythen, Monty
Source	PMC
abstract	Intravenous fluid administration should be considered as any other pharmacological prescription. There are three main indications: resuscitation, replacement, and maintenance. Moreover, the impact of fluid administration as drug diluent or to preserve catheter patency, i.e., fluid creep, should also be considered. As for antibiotics, intravenous fluid administration should follow the four Ds: drug, dosing, duration, de-escalation. Among crystalloids, balanced solutions limit acid–base alterations and chloride load and should be preferred, as this likely prevents renal dysfunction. Among colloids, albumin, the only available natural colloid, may have beneficial effects. The last decade has seen growing interest in the potential harms related to fluid overloading. In the perioperative setting, appropriate fluid management that maintains adequate organ perfusion while limiting fluid administration should represent the standard of care. Protocols including a restrictive continuous fluid administration alongside bolus administration to achieve hemodynamic targets have been proposed. A similar approach should be considered also for critically ill patients, in whom increased endothelial permeability makes this strategy more relevant. Active de-escalation protocols may be necessary in a later phase. The R.O.S.E. conceptual model (Resuscitation, Optimization, Stabilization, Evacuation) summarizes accurately a dynamic approach to fluid therapy, maximizing benefits and minimizing harms. Even in specific categories of critically ill patients, i.e., with trauma or burns, fluid therapy should be carefully applied, considering the importance of their specific aims; maintaining peripheral oxygen delivery, while avoiding the consequences of fluid overload.
has issue date	2020-05-24(xsd:dateTime)
bibo:doi	10.1186/s13613-020-00679-3
has license	cc-by
sha1sum (hex)	c30e9acc00ea2edb4d64288751f14f6848d4d9eb
schema:url	https://doi.org/10.1186/s13613-020-00679-3
resource representing a document's title	Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)
has PubMed Central identifier	PMC7245999
schema:publication	Ann Intensive Care
resource representing a document's body	covid:c30e9acc00ea2edb4d64288751f14f6848d4d9eb#body_text
is schema:about of	named entity 'summarizes' named entity 'Protocols' named entity 'fluid' named entity 'continuous' named entity 'R.O.S.E.' named entity 'targets' named entity 'FLUID' named entity 'BASE' named entity 'SEEN' named entity 'RESUSCITATION' named entity 'perioperative' named entity 'permeability' named entity 'Intravenous fluid' named entity 'prescription' named entity 'peripheral' named entity 'administration' named entity 'diluent' named entity 'chloride' named entity 'alterations' named entity 'trauma' named entity 'acid-base' named entity 'drug' named entity 'strategy' named entity 'maximizing' named entity 'solutions' named entity 'decade' named entity 'creep' named entity 'fluid' named entity 'burns' named entity 'growing' named entity 'perfusion' named entity 'antibiotics' named entity 'albumin' named entity 'intravenous fluid administration' named entity 'de-escalation' named entity 'fluid management' named entity 'renal dysfunction' named entity 'critically ill patients' named entity 'perioperative' named entity 'critically ill patients' named entity 'continuous fluid' named entity 'perfusion' named entity 'hemodynamic' named entity 'crystalloids' named entity 'perioperative' named entity 'preserve' named entity 'natriuretic peptides' named entity 'de-escalation' named entity 'fluid resuscitation' named entity '2.5' named entity 'acetated Ringer's' named entity 'electrolytes' named entity 'metabolic alkalosis' named entity 'HES' named entity 'De-escalation' named entity 'intensive care units' named entity 'acidosis' named entity 'low volume' named entity 'hyperchloremic metabolic acidosis' named entity 'edema' named entity 'perfusion' named entity 'permeability' named entity 'ion' named entity 'fluid balance' named entity 'fluid overload' named entity 'acute lung injury' named entity 'thrombomodulin' named entity 'mEq/L' named entity 'critically ill patients' named entity 'fluid balance' named entity 'PlasmaLyte'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software